Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $75
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group has maintained an 'Outperform' rating on CVS Health and raised its price target from $62 to $75, indicating a positive outlook for the company's stock.
October 08, 2024 | 5:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evercore ISI Group has maintained an 'Outperform' rating on CVS Health and increased the price target from $62 to $75, suggesting a positive short-term outlook for the stock.
The 'Outperform' rating and increased price target from a reputable analyst group like Evercore ISI suggest confidence in CVS Health's future performance, likely leading to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100